| Product Type | Impurity Standards |
| CAT. No. | MRL-R18029 |
| CAS. No. | 179676-15-4 |
| Mol. Formula | C11H18N2 |
| Mol. Weight | 178.27 |
| Synonyms | NA |
| Chemical Name | 3-((Dimethylamino)methyl)-N,N-dimethylaniline |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | In stock |
3-((Dimethylamino)Methyl)-N,N-Dimethylaniline with CAS No: 179676-15-4 is an impurity standard of Rivastigmine. Rivastigmine is a medication used in the treatment of Alzheimers disease and Parkinsons disease-related dementia. Structurally, it is a carbamate derivative. Rivastigmine belongs to the class of acetylcholinesterase inhibitors, and its primary mechanism of action involves increasing levels of acetylcholine, a neurotransmitter involved in cognitive function, by inhibiting its breakdown. This is particularly beneficial in conditions where there is a deficiency of acetylcholine, as seen in Alzheimers and Parkinsons disease-related dementia. Rivastigmine is available in various formulations, including oral capsules and transdermal patches, allowing for flexibility in administration. Buy high quality 3-((Dimethylamino)Methyl)-N,N-Dimethylaniline from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of 3-((Dimethylamino)Methyl)-N,N-Dimethylaniline